In recognition of World Asthma Day 2024, Alkem Laboratories (Alkem) has announced 600-700 camps across India, collaborating with nearly 100 hospitals in tier-1 and tier-2 cities under its ‘Reliever Free India’ initiative.
Reportedly, this nationwide initiative was launched in 2023 with an aim to develop asthma management by advocating for a shift in focus from reliance on reliever medications to the importance of controller medications. Through this campaign, Alkem Laboratories seeks to educate patients, healthcare professionals, and the general public about the benefits of controller medications in preventing asthma symptoms and reducing the need for rescue medication.
“We’ve engaged with over 500 camps since the start of our campaign. This year, we aim to be expanding our commitment by organising at least 600 camps and clinics to raise awareness about asthma and its management. Our goal is to empower patients with the knowledge they need to take control of their health. Through the ‘Reliever Free India’ campaign, we intend to be promoting an approach to asthma management, aiming to improve outcomes, and enhance quality of life for individuals with this condition,” an Alkem Laboratories spokesperson said.